Featured


  • Breaking News | Clinical Trial Materials | Promotions & Moves
    Catalent Bolsters Clinical Operations

    Catalent Bolsters Clinical Operations

    Appoints Ricci Whitlow to lead clinical supply services business.
    01.29.20

  • Breaking News | Cold Chain Management | Industry News | Supply Chain
    Pelican BioThermal Expands Global Reach

    Pelican BioThermal Expands Global Reach

    Extends services to major pharma market in Oceania.
    01.29.20

  • Bio News | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News
    Lonza Expands Mfg. Tie-up with Rocket Pharma

    Lonza Expands Mfg. Tie-up with Rocket Pharma

    Ongoing collaboration and tech transfers started in 2018 for the clinical manufacturing of LAD-I.
    01.29.20


  • Bio News | Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
    WuXi Biologics Enters Fight Against Coronavirus

    WuXi Biologics Enters Fight Against Coronavirus

    Enables development of multiple neutralizing antibodies for novel coronavirus.
    01.29.20

  • Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
    3P Bio Completes Vaccine Mfg. Process

    3P Bio Completes Vaccine Mfg. Process

    Validation batches of the vaccine against equine strangles Strangvac is completed.
    01.29.20

  • Breaking News | CRO News | R&D
    Bionetix, ProQinase, MercachemSyncom Enter Research Project

    Bionetix, ProQinase, MercachemSyncom Enter Research Project

    The goal of the three-party team is to advance the project to the clinical phase by 2023.
    01.29.20


  • QA/QC
    Quality Management: Preserving and Perpetuating Your Record

    Quality Management: Preserving and Perpetuating Your Record

    CDMOs must ensure that their top priority be delivering the highest quality products.
    Colleen Herczak, Vice President of Quality, Grand River Aseptic Manufacturing 01.28.20

  • Biosimilars
    The Similar Mantra

    The Similar Mantra

    Early birds bet big on biosimilars.
    S. Harachand, Contributing Editor 01.28.20

  • Supply Chain
    What We Have is Failure to Communicate

    What We Have is Failure to Communicate

    When it comes to implementing track and trace technology, why is Pharma dragging its feet?
    Emil W. Ciurczak, DoraMaxx Consulting 01.28.20


  • Vision: 2020

    Vision: 2020

    You have exactly 366 days in 2020 to bring your clarity of vision to reality.
    Ben Locwin 01.28.20

  • DCAT Week ’20: Clearly the place to be

    DCAT Week ’20: Clearly the place to be

    March 23 – 26, 2020, New York City.
    01.28.20

  • Realizing the Full Potential of Precision Medicine in Oncology

    Realizing the Full Potential of Precision Medicine in Oncology

    Innovation in oncology drug development is being driven by “precision medicine."
    Peter Larson, Executive Medical Director, Hematology-Oncology, Premier Research 01.28.20

  • Advanced Therapy Manufacturing Trends

    Advanced Therapy Manufacturing Trends

    A look at chain of identity and custody in personalized therapies, plus their core differences from traditional pharma.
    Heidi Hagen, Chief Strategy Officer and Co-founder, Vineti 01.28.20

  • Serialization
    Assessing Current DSCSA Implementation

    Assessing Current DSCSA Implementation

    A detailed view of the industry’s progress with DSCSA Serialization Requirements.
    Peter Sturtevant, Senior Director Industry Development - Pharmaceuticals, GS1 US 01.28.20

  • Cold Chain Management | Supply Chain
    Pharmaceutical Cold Chain Expertise

    Pharmaceutical Cold Chain Expertise

    The missing ingredient in the CMO/CDMO offering.
    James Klingelhoefer, Director of Sales - Americas, Pelican BioThermal 01.28.20